Viewing Study NCT01836367


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-01-02 @ 9:58 AM
Study NCT ID: NCT01836367
Status: COMPLETED
Last Update Posted: 2013-12-31
First Post: 2013-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp
Sponsor: Icahn School of Medicine at Mount Sinai
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GCO 13-0026
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View